Association of antidiabetic medication use, cognitive decline, and risk of cognitive impairment in older people with type 2 diabetes: Results from the population-based Mayo Clinic Study of Aging.
Alexandra M V WennbergClinton E HagenKelly EdwardsRosebud O RobertsMary M MachuldaDavid S KnopmanRonald C PetersenMichelle M MielkePublished in: International journal of geriatric psychiatry (2018)
These findings suggest that metformin use, as compared to management of diabetes with other treatments, is not associated with cognitive test performance. However, metformin was associated with incident MCI diagnosis.